In patient samples acquired prior to Neoadjuvant Chemotherapy (NAC), the presence of both IL-33 and FOXP3 proteins was confirmed, with IL-33 detected primarily in the stromal tumor lesion. This evidence concerns the gene FOXP3 and neoplasm.